Orasure Technologies Inc
Orasure Technologies Inc (OSUR) Covered Calls
As of September 25, 2026, OSUR has 1 covered call opportunities in the coming three months. Return ranges from 26.6 to 26.6% until expiration. Annualized return ranges from 85.1 to 85.1%. The nearest expiration is January 15, 2027. Maximum potential profit is $106.
Read more
Running OSUR covered calls helps you generate consistent income from Orasure Technologies Inc's shares you already own, turning a long stock position into a yield-producing asset. A covered call on Orasure Technologies Inc involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best OSUR covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if OSUR stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling OSUR covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given Orasure Technologies Inc covered call is worth writing.
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, Diagnostics and Molecular Solutions. The company's principal products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.
saliva alcohol test. It also offers genomic products under the Oragene and ORAcollect brands; microbiome collection products; and GenoFIND genomics laboratory services. In addition, the company provides ORAcollect, RNA and OMNIgene, and RAL collection devices for use in connection with COVID-19 molecular testing; offers Colli-Pee collection device for the volumetric collection of first void urine; and manufactures and sells kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the academic research and commercial applications, including ancestry, disease risk management, lifestyle, and animal testing. Further, it provides other diagnostic products, such as immunoassays and other in vitro diagnostic tests. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians' offices, and commercial and industrial entities. OraSure Technologies, Inc. was incorporated in 2000 and is headquartered in Bethlehem, Pennsylvania.
Income-focused investors, long-term OSUR holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling OSUR covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best Orasure Technologies Inc covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryMedical Instruments & Supplies
- SectorHealthcare
- IV percentile61.11% Neutral
- Market cap (M$)271
- 52 weeks high-14.19%
- 52 weeks low88.94%
- Analyst recommendationHold
3.00 - Target price$4.00
1.78% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-04
- P/E—
- Future P/E—
- EPS (ttm)-0.69
- EPS growth next 5 years—
As of September 25, 2026
| 2027-01-15 | 114 | 5.00 | 25.31 | 0.05 | 0.40 | 106.00 | 26.57 | 85.06 | -1.25 | +0.31 | 213 | 0.35 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best OSUR covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→